Published in Medical Letter on the CDC and FDA, January 22nd, 2006
The patent claims the combined use of at least two spectroscopic methods for measuring biochemical and morphological, or structural, changes that occur with diseases such as cancer. The biochemical spectroscopic methods claimed include fluorescence, time resolved fluorescence and fluorescence anisotropy. The morphological spectroscopic methods include absorption,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.